| 000 | 01645 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514035459.0 | ||
| 264 | 0 | _c20020718 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a1097-6744 | ||
| 024 | 7 |
_a10.1067/mhj.2002.123145 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuvin, Jeffrey T | |
| 245 | 0 | 0 |
_aA novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cJul 2002 |
||
| 300 |
_a165-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xblood |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xenzymology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNiacin _xtherapeutic use |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xmetabolism |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 |
_aVasodilation _xphysiology |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 700 | 1 | _aRämet, Maria E | |
| 700 | 1 | _aPatel, Ayan R | |
| 700 | 1 | _aPandian, Natesa G | |
| 700 | 1 | _aMendelsohn, Michael E | |
| 700 | 1 | _aKaras, Richard H | |
| 773 | 0 |
_tAmerican heart journal _gvol. 144 _gno. 1 _gp. 165-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1067/mhj.2002.123145 _zAvailable from publisher's website |
| 999 |
_c11988224 _d11988224 |
||